Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL2L1 Antikörper

BCL2L1 Reaktivität: Human, Maus, Ratte, Schwein WB, IF, IHC (p), IHC (fro), EIA Wirt: Maus Monoclonal 2H12 unconjugated
Produktnummer ABIN187417
  • Target Alle BCL2L1 Antikörper anzeigen
    BCL2L1 (BCL2-Like 1 (BCL2L1))
    Reaktivität
    • 212
    • 131
    • 114
    • 46
    • 25
    • 11
    • 9
    • 7
    • 5
    • 5
    • 4
    • 2
    • 2
    • 1
    Human, Maus, Ratte, Schwein
    Wirt
    • 157
    • 74
    • 2
    Maus
    Klonalität
    • 146
    • 87
    Monoklonal
    Konjugat
    • 124
    • 24
    • 12
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BCL2L1 Antikörper ist unkonjugiert
    Applikation
    • 161
    • 71
    • 62
    • 58
    • 53
    • 32
    • 32
    • 28
    • 28
    • 21
    • 17
    • 9
    • 6
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)
    Spezifität
    Reacts specifically with the Bcl-xL protein. Species Reactivity: Human, mouse and rat. Others not tested.
    Immunogen
    Synthetic peptide corresponding to aa 3-14 of the human Bcl-xL protein.
    Klon
    2H12
    Isotyp
    IgG2a
    Top Product
    Discover our top product BCL2L1 Primärantikörper
  • Applikationshinweise
    Western blot: Use at 1-5 µg/mL. The optimal dilution for a specific application should be determined by the researcher.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    100 µg purified IgG at approx. 1 mg/mL. Purified from ascites fluid.
    Lagerung
    -20 °C
  • Target
    BCL2L1 (BCL2-Like 1 (BCL2L1))
    Andere Bezeichnung
    Bcl-2-like 1 (BCL2L1 Produkte)
    Synonyme
    BCL-XL/S antikoerper, BCL2L antikoerper, BCLX antikoerper, BCLXL antikoerper, BCLXS antikoerper, Bcl-X antikoerper, PPP1R52 antikoerper, bcl-xL antikoerper, bcl-xS antikoerper, Bcl(X)L antikoerper, Bcl-XL antikoerper, Bcl-Xs antikoerper, Bcl2l antikoerper, BclX antikoerper, bcl-x antikoerper, Bcl-xl antikoerper, Bclx antikoerper, bcl-X antikoerper, Bcl-xL antikoerper, BCL-XL antikoerper, BCL2L1 antikoerper, bcl-XL antikoerper, bcl-x(l) antikoerper, bcl-xl/s antikoerper, bcl-xs antikoerper, bcl2l antikoerper, bclx antikoerper, bclxl antikoerper, xR11 antikoerper, bcl-xl antikoerper, blp1 antikoerper, cb1021 antikoerper, zfBLP1 antikoerper, BCL2 like 1 antikoerper, BCL2-like 1 antikoerper, Bcl2-like 1 antikoerper, BCL2-like 1 L homeolog antikoerper, bcl2-like 1 antikoerper, BCL2L1 antikoerper, Bcl2l1 antikoerper, bcl2l1 antikoerper, bcl2l1.L antikoerper
    Hintergrund
    Bcl-xL is structurally related to the Bcl-2 gene and is a member of the Bcl-2 family of oncoproteins. Overexpression of Bcl-xL to other Bcl-2 members is believed to promote cell survival, its ratio to other Bcl-2 family members is believed to modulate the apoptotic process.
    Pathways
    Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Sie sind hier:
Kundenservice